eRAM
encyclopedia of Rare Disease Annotation for Precision Medicine
| Disease | non-alcoholic fatty liver disease |
| Comorbidity | C0004153|atherosclerosis |
| Sentences | 26 |
| PubMedID- 21664615 | We evaluated liver mrna expression of 84 genes encoding proteins involved in the atherosclerosis pathway in patients with nafld proven through biopsy in a case-control design, and examined the putative role of the histological disease severity in the molecular events associated with the atherogenic profile. |
| PubMedID- 24069270 | Pnpla3 gg genotype and carotid atherosclerosis in patients with non-alcoholic fatty liver disease. |
| PubMedID- 22814750 | nonalcoholic fatty liver disease is associated with atherosclerosis in middle-aged and elderly chinese. |
| PubMedID- 23626730 | Background: non-alcoholic fatty liver disease (nafld) is associated with cardiovascular atherosclerosis independent of classical risk factors. |
| PubMedID- 23834053 | nafld correlates with atherosclerosis, insulin resistance and diabetes mellitus. |
| PubMedID- 21525484 | Several alterations that are linked with the pathogenesis of atherosclerosis were reported in patients with nafld, including endothelial dysfunction, alterations of the coronary and carotid arteries, abnormal cardiac energy metabolism, and low-grade inflammation. |
| PubMedID- 22676459 | Background: insulin resistance (ir) is the major driving force behind development and progression of atherosclerosis in patients with nonalcoholic fatty liver disease (nafld). |
| PubMedID- 21504583 | nafld is associated with accelerated atherosclerosis [10], and oxidative stress is now believed to be an important factor in the development/progression of the condition [3-5]. |
| PubMedID- 23085576 | Evaluation of early atherosclerosis markers in patients with nonalcoholic fatty liver disease. |
| PubMedID- 22385985 | Objectives: hcv and nafld are associated with atherosclerosis in general population. |
| PubMedID- 25729707 | A recent comprehensive systematic review of 27 studies showed that nafld is associated with subclinical atherosclerosis independent of traditional risk factors and metabolic syndrome and across a wide range of ethnicities [4]. |
| PubMedID- 22359630 | Objectives: nonalcoholic fatty liver disease (nafld) is associated with advanced atherosclerosis and a higher risk of cardiovascular disease. |
| PubMedID- 25436098 | (2007) showed increased liver enzymes in patients with nafld might be associated with severity of atherosclerosis (19). |
| PubMedID- 20835270 | Clinical studies showed that the severity of histopathological features in nafld is strongly associated with early carotid atherosclerosis, insulin resistance, and the presence of metabolic syndrome34. |
| PubMedID- 25500875 | For instance, our previous study found that nafld was associated with atherosclerosis in middle-aged and elderly chinese individuals, independent of conventional cardiovascular disease risk factors or metabolic syndrome5. |
| PubMedID- 24956534 | In a population-based cross-sectional sample of middle-aged adults free from liver or heart disease, we tested the hypothesis that nafld is associated with subclinical atherosclerosis (coronary artery (cac) and abdominal aortic calcification (aac)) independent of obesity. |
| PubMedID- 23185655 | Conclusion: nafld is significantly associated with carotid atherosclerosis in non-diabetic outpatients even without mets. |
| PubMedID- 22748277 | nonalcoholic fatty liver disease is associated with subclinical atherosclerosis independent of obesity and metabolic syndrome in asian indians. |
| PubMedID- 24794207 | Adiponectin has recently been considered as a possible link between liver dysfunction and atherosclerosis in patients with nonalcoholic fatty liver disease (nafld). |
| PubMedID- 25300437 | We examined whether transient elastography (te) defined nafld was associated with atherosclerosis in rtrs, as measured by ultrasound in the carotid arteries. |
| PubMedID- 24381427 | A study of carotid atherosclerosis in patients with non-alcoholic fatty liver disease. |
| PubMedID- 24075754 | Conclusion: there is evidence to support the association of nafld with subclinical atherosclerosis independent of traditional risk factors and metabolic syndrome. |
| PubMedID- 25816034 | In contrast to our findings, vanwagner et al34 demonstrated that nafld was not associated with subclinical atherosclerosis as measured by coronary artery calcification, and tarantino et al35 also indicated that the severity of hepatic steatosis was not associated with carotid intima media thickness in obese patients. |
| PubMedID- 23924883 | Conclusions: patients with smaller retinal avr (<0.7) are likely to be at increased risk for cad and carotid atherosclerosis in patients with nafld even without hypertension or diabetes. |
| PubMedID- 24328674 | Endothelial dysfunction and carotid atherosclerosis in non-alcoholic fatty liver disease. |
| PubMedID- 25603326 | Association of nafld with subclinical atherosclerosis and coronary-artery disease: meta-analysis. |
Page: 1